Ann Hanham

Director/Board Member at SCYNEXIS, INC.

Net worth: 65 294 $ as of 2026-05-30

73 year

70 connections

Health Technology

Consumer Services

Distribution Services

Profile

Ann F.
Hanham was the founder of InterMune, Inc. (1998) as Vice President-Clinical & Regulatory Affairs.
Dr. Hanham is the founder of BAR Capital Management LLC (2013) as Managing Director & Founding Partner.
Dr. Hanham is the founder of Bar Capital LLC (2013) as Managing Partner.
Dr. Hanham is currently an Independent Director at SCYNEXIS, Inc. since 2008.
Former positions include Chairman at Adlyfe, Inc., Medical Director at Celtrix Pharmaceuticals, Inc. (1991-1995), Director at Acusphere, Inc., Director at Immunicon Corp., Director at Sention, Inc., Director at Aerovance, Inc., Director at BioMimetic Therapeutics, Inc. (2006), Director at Waterstone Pharmaceuticals, Inc., Managing Director & General Partner at Burrill LLC (2000-2013), Director at Biotie Therapies Oy (2010), Director at Targacept, Inc. (2006), Director at Veritas Medicine, Inc., Independent Director at Endocyte, Inc. (2011-2018), Senior Director-Oncology Product Development at Otsuka America Pharmaceutical, Inc. (1995-1998), Director at Logical Therapeutics, Inc., Director at NewBridge Pharmaceuticals FZ LLC, Director at Taiwan Liposome Co., Ltd., Lead Independent Director at HTG Molecular Diagnostics, Inc. (2019-2021), and Senior Manager-Medical Affairs at Becton, Dickinson & Co. (1984-1991).
Education includes a doctorate from the University of British Columbia, a graduate degree from Simon Fraser University, and an undergraduate degree from the University of Toronto.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SCYNEXIS, INC. 0.12%	2026-06-25	92,616 ( 0.12% )	65 294 $	2026-05-30

Ann Hanham active positions

Companies	Position	Start
SCYNEXIS, INC.	Director/Board Member	2008-11-30

All active positions of Ann Hanham

Former positions of Ann Hanham

Companies	Position	End
ENDOCYTE, INC.	Director/Board Member	2017-12-31
Bar Capital LLC	Corporate Officer/Principal	2017-02-28
BAR Capital Management LLC BAR Capital Management LLC Investment ManagersFinance BAR Capital Management LLC invests in companies located globally. The firm focuses on companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, human healthcare & related medical technologies, wellness & nutraceuticals, agbio and industrial biotechnology (biomaterials/bioprocess). It provides financing for seed, early stage and mezzanine capital requirements with an investment size ranging between $1 and $20 million per company.	Corporate Officer/Principal	2016-12-30
Burrill LLC Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions.	Chief Executive Officer	2013-10-31
Veritas Medicine, Inc. Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Operates an online database of clinical trials	Director/Board Member	2011-05-15

See the detail of Ann Hanham's experience

Training of Ann Hanham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ann Hanham's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	26
Becton, Dickinson & Co. Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products	Health Technology
Celtrix Pharmaceuticals, Inc. Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops potential therapeutic products	Health Technology
InterMune, Inc. InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases	Health Technology
Acusphere, Inc. Acusphere, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs	Health Technology
Immunicon Corp. Immunicon Corp. Medical SpecialtiesHealth Technology Develops cell-based research and diagnostic products	Health Technology
Sention, Inc. Sention, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products	Health Technology
Aerovance, Inc. Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases	Distribution Services
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions	Commercial Services
BioMimetic Therapeutics, Inc. BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells protein therapeutics for tissue and organ regeneration	Health Technology
Adlyfe, Inc. Adlyfe, Inc. Medical DistributorsDistribution Services Develops diagnostic products	Distribution Services
Waterstone Pharmaceuticals, Inc. Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in activities ranging from drug discovery of proprietary new chemical entities, custom development and manufacturing services, and generic drug development and manufacturing	Health Technology
Burrill LLC Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions.	Finance
Biotie Therapies Oy Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products	Health Technology
SCYNEXIS, Inc. SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections	Health Technology
Targacept, Inc. Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies	Health Technology
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Simon Fraser University Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Veritas Medicine, Inc. Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Operates an online database of clinical trials	Technology Services
Endocyte, Inc. Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases	Health Technology
Otsuka America Pharmaceutical, Inc. Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products	Health Technology
Logical Therapeutics, Inc. Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat diseases associated with inflammation	Health Technology
NewBridge Pharmaceuticals FZ LLC NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, therapeutics, and medical devices	Health Technology
Taiwan Liposome Co., Ltd. Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company	Health Technology
BAR Capital Management LLC BAR Capital Management LLC Investment ManagersFinance BAR Capital Management LLC invests in companies located globally. The firm focuses on companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, human healthcare & related medical technologies, wellness & nutraceuticals, agbio and industrial biotechnology (biomaterials/bioprocess). It provides financing for seed, early stage and mezzanine capital requirements with an investment size ranging between $1 and $20 million per company.	Finance
Bar Capital LLC